Latest Earnings Results: Q4 '26
Estimated EPS
$2.89
Reported EPS
$2.95
Surprise
+1.98%
Estimated Rev
$1.46B
Reported Rev
$1.46B
Surprise
+0.16%
• Reported GAAP EPS of $2.65 up 2.32% YoY • Reported revenue of $1.46B up 8.58% YoY • Resmed Inc. is guiding to more than $1.85 billion in capital to be returned to shareholders through share repurchases and dividends during fiscal year 2027, with a 10% quarterly dividend increase.
Generated by Stocktwits using AI and company-reported earnings data for Q4 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q1 '27 | $2.69 | -- | -- | N/A |
Q4 '26 | $2.89 | $2.95 | 1.98% | BEAT |
Q3 '26 | $2.80 | $2.86 | 2.32% | BEAT |
Q2 '26 | $2.74 | $2.81 | 2.73% | BEAT |
Q1 '26 | $2.52 | $2.55 | 1.32% | BEAT |